• English
  • Español

Background of our inventions

We provide some information about how our owned technology works

WMicrotracker ONE

The method is based on detecting the scattering of light caused by the movement of organisms when they are subjected to microbeams of infrared light.

The technology is implemented as a grid of infrared light microbeams: 2 microbeams per well of 96 wells, wavelength 880nm, 100 micrometers in diameter, power <1mW / mm2)

When any animal scatter the light from the microbeams, a locomotor activity counter is increased, and the result can be seen as the activity accumulated over time (total or kinetic activity).

This approach has been previously used to study circadian rhythms of fruit flies. Our innovation rely in the sensitivity obtained by the microbeams, allowing the quantification of quasi-microscopic organisms.

The invention of the method is published in the Journal of Neuroscience Methods 161 (2007) 273-280 and is protected by PCT / IB2007 / 054628 – “Small organism locomotor recording procedure and device, behavioral record obtained and use of same” and associated.


The method is based on subjecting the organisms to an array of thousands of microbeams of light that are very close to each other. In this way, not only the movement of animals can be detected but also their position in the culture medium.

The innovation rely in applying a phenomenon called optical interferometry, which enables us to acquire shadows of small organisms without the need for microscopes or high resolution captures. It allows real-time processing.

The method is protected by the patent “Procedure and automatic recording device for locomotion of nematodes or small organisms of similar sizes by temporary interferometry of light microbeams.” AR20190100121, PCT/ES2020/070029 and related protection.


Our Lab as a Service platform is based on the integration of reader machines with IOT, robotic arms and several software layers. The technology allows to run automated parallel experiments with a simple graphical interface. Protocol recipes are preloaded and there is no need for robotic code programming.

The technology is protected by US patent  US20200098449A1 “Remote-controlled Automated System For Drug Testing And Screening” owned by Phylumtech.